A couple of weeks ago the U.S. Food and Drug Administration, or FDA, announced that it had formally warned more than a dozen companies hawking what the agency said were sham cancer remedies. One of the most notable was AIE Pharmaceuticals.
AIE had at least 5 of its products called out by the FDA for making unallowed claims covering a wide variety of conditions, including hepatitis, arthritis, several types of cancer and more.
The Cevrogin product was dinged for claims made on at least 2 websites, where it was claimed that the product could reduce diabetics’ need for insulin, lower bad cholesterol and repair damage to liver, kidney and muscle tissues.
The company’s Cholestrien product was touted mainly for its cholesterol-lowering effects. But it also caught the FDA’s eye for promises to prevent hardening of the arteries and to reduce blood pressure.
On at least 3 different websites AIE’s ImmunPro product promised to kill germs, fight fevers and treat parasitic infections like malaria. It also claimed to be “proven effective” against HIV, herpes and all types of cancer.
The Livral Complex product focuses on liver health and toots its horn as “The Alternative Hope For Hepatitis, Cirrhosis, Cancer and AIDS”. It also promises to lengthen the lives of alcoholics suffering from cirrhosis.
Prozidan is especially proud of its St. John’s Wort ingredient. The company claims that the herb treats conditions, including certain sexually transmitted bacterial infections, bloody diarrhea and “worms”. It is also claimed to improve depression, anxiety and insomnia. And if you’re suffering from anorexia, Prozidan can help with that, too, the company suggests.
Troublesome Facebook Claims
The company was also warned about its use of social media to advocate for its supplements. A Facebook posting from 2013 was noted for claims covering hepatitis, HIV and a parasitic infection known as snail fever.
None of the products mentioned in the FDA’s warning letter to AIE have been officially recognized as safe or effective for the aforementioned medical issues so they’ve been slapped with the label “new drugs”. And they’re further “misbranded”, says the agency, because they’re marketed as treatments for conditions that the average consumer cannot accurately self-diagnose or treat alone.
AIE was given the normal 15 working days to address the FDA’s allegations and it appears to have already done so. The Facebook posting is no longer available and a search for some of the website claims found me empty-handed.